Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1697
-0.0053 (-3.03%)
At close: Jul 10, 2026, 4:00 PM EDT
0.1690
-0.0007 (-0.41%)
After-hours: Jul 10, 2026, 7:56 PM EDT
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $82.96 million as of July 10, 2026. Its market cap has decreased by -73.16% in one year.
Market Cap
82.96M
Enterprise Value
186.68M
1-Year Change
-73.16%
Ranking
Category
Stock Price
$0.17
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $82.96M, a decrease of -91.66%. That is a compound annual growth rate of -28.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 82.96M | -88.44% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeurAxis | 88.42M |
| Atara Biotherapeutics | 87.94M |
| MAIA Biotechnology | 87.55M |
| Rani Therapeutics Holdings | 85.13M |
| Telomir Pharmaceuticals | 84.59M |
| Acrivon Therapeutics | 83.89M |
| Rallybio | 83.34M |
| Entera Bio | 81.58M |